On Feb. 13, 2020, National Institutes of Health (NIH) scientists announced that the experimental antiviral remdesivir successfully prevented disease in rhesus macaques infected with Middle East respiratory syndrome coronavirus (MERS-CoV). The study results appeared in the Proceedings of the National Academy of Sciences.